menu
    • menu

    Company profile for Star Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need. Our innovation engine starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star Therapeutics is a biotechnology company with a mission to...
    Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need. Our innovation engine starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Star TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    201 Haskins Way, 5th Floor South San Francisco, CA 94080
    Telephone
    Telephone
    +1 8887421338
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://star-therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/star-tx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/STAR_Biotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Star Therapeutics Secures FDA RPD, BTD for VGA039 in VWD
    Star Therapeutics Secures FDA RPD, BTD for VGA039 in VWD

    21 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-21/star-therapeutics-receives-fda-rare-pediatric-disease-and-breakthrough-therapy-designations-for-vga0

    PHARMIWEB
    21 Apr 2026
    Share Share
    Star Therapeutics Presents at 44th JP Morgan Healthcare Conf
    Star Therapeutics Presents at 44th JP Morgan Healthcare Conf

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251229847126/en/Star-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference-on-Monday-January-12

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Star Therapeutics' VGA039 Cuts VWD Bleeding at ASH
    Star Therapeutics' VGA039 Cuts VWD Bleeding at ASH

    06 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251205981362/en/Star-Therapeutics-Presents-Interim-Data-from-Phase-12-Multidose-Study-of-VGA039-in-Von-Willebrand-Disease-Demonstrating-Substantial-Bleed-Reductions-in-All-Patients-at-ASH-Annual-Meeting

    BUSINESSWIRE
    06 Dec 2025
    Share Share
    Star Tx To Present Interim Ph 1/2 VGA039 Data at ASH
    Star Tx To Present Interim Ph 1/2 VGA039 Data at ASH

    03 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031148432/en/Star-Therapeutics-to-Present-Interim-Data-from-Phase-12-Multidose-Study-of-VGA039-in-von-Willebrand-disease-at-ASH-Annual-Meeting

    BUSINESSWIRE
    03 Nov 2025
    Share Share
    Star Therapeutics Secures $125m In Series D Funding
    Star Therapeutics Secures $125m In Series D Funding

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250929595423/en/Star-Therapeutics-Announces-Oversubscribed-%24125-Million-Series-D-Financing

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Star Therapeutics Gains FDA Fast Track For VGA039 In VWD
    Star Therapeutics Gains FDA Fast Track For VGA039 In VWD

    06 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250106373894/en

    BUSINESSWIRE
    06 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search